Literature DB >> 3143107

A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.

R L Cardoni1, M E Rottenberg, E L Segura.   

Abstract

Infective forms of Trypanosoma cruzi were used to evaluate the complement-mediated lysis (CoML) of the parasites in the presence of anti-T. cruzi sera. Parasites released to the supernatant from infected Vero cell monolayers were used. Cultures of 1-3 x 10(6) parasites/ml were incubated for 24 h in the presence of 10 microCi/ml of 3H-uridine. Under these conditions 10(5) parasites used for each determination incorporated about 9600 dpm of the radioactive material. The release of tritium from labelled parasites after incubation with antiserum and complement correlated with the percentage of lysed parasites evaluated by optical microscopy. Normal sera from humans, a guinea pig, a rabbit, and mice were tested as complement sources. Only human sera were suitable for the evaluation of CoML in the presence of antisera, and the levels of lysis attained depended on the serum donor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143107     DOI: 10.1007/bf00531627

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  16 in total

1.  Immunologic studies on Trypanosoma cruzi. IV. Serial transfer of organisms from immune to nonimmune mice.

Authors:  I G KAGAN; L NORMAN
Journal:  J Parasitol       Date:  1962-08       Impact factor: 1.276

2.  Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.

Authors:  L A Muller; N Añasco; S M González Cappa
Journal:  Exp Parasitol       Date:  1986-06       Impact factor: 2.011

3.  Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.

Authors:  N Yoshida
Journal:  Exp Parasitol       Date:  1986-04       Impact factor: 2.011

4.  Cross-reactivity of lytic antibodies against blood forms of Trypanosoma cruzi.

Authors:  F Kierszenbaum
Journal:  J Parasitol       Date:  1976-02       Impact factor: 1.276

5.  [Characteristics of infectivity of 3 cultured populations of Trypanosoma cruzi].

Authors:  E L Segura; E Subias; M Esteva; P Cabeza Meckert; A Bronzina; R P Laguens
Journal:  Medicina (B Aires)       Date:  1980       Impact factor: 0.653

6.  Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments.

Authors:  T L Kipnis; A U Krettli; W Dias da Silva
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

7.  Protective effects of specific antibodies in Trypanosoma cruzi infections.

Authors:  A U Krettli; Z Brener
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Authors:  D B Budzko; M C Pizzimenti; F Kierszenbaum
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

9.  Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.

Authors:  A U Krettli; Z Brener
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

10.  Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.

Authors:  S Schenkman; M L Güther; N Yoshida
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

View more
  1 in total

1.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.